Survival outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in selected patients with stage IV gastric adenocarcinoma – A Canadian case series

Despite advances in systemic therapy, metastatic gastric cancer is associated with a poor prognosis. As peritoneal disease is common, several studies looked at the potential benefits of hyperthermic intraperitoneal chemotherapy (HIPEC) in this context, with encouraging results. However, no Canadian...

Full description

Saved in:

Bibliographic Details
Published in:	European journal of surgical oncology Vol. 51; no. 8; p. 110000
Main Authors:	Bénard, Florence, Marcil, Stéphanie, Mack, Lloyd, Deban, Melina, Bildersheim, Michael, Bouchard-Fortier, Antoine, Osman, Yasmin, Mercier, Frédéric, Purich, Kieran, Haase, Erika, Schiller, Dan, Soucisse, Mikael, Sidéris, Lucas, Leblanc, Guy, Dubé, Pierre, Boulanger-Gobeil, Cindy, Hamilton, Trevor, Gervais, Mai-Kim
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.08.2025
Subjects:	Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - secondary Adenocarcinoma - therapy Adult Aged Canada Carcinomatosis Cytoreduction Cytoreduction Surgical Procedures Female Gastric cancer HIPEC Humans Hyperthermic Intraperitoneal Chemotherapy Male Metastatic Middle Aged Neoplasm Staging Peritoneal Peritoneal Neoplasms - secondary Peritoneal Neoplasms - therapy Retrospective Studies Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach Neoplasms - therapy Survival Rate Canada Peritoneal Carcinomatosis Cytoreduction Metastatic HIPEC Gastric cancer
ISSN:	0748-7983, 1532-2157, 1532-2157
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!